PMID- 24923386 OWN - NLM STAT- MEDLINE DCOM- 20150511 LR - 20171116 IS - 1205-7541 (Electronic) IS - 0008-4212 (Linking) VI - 92 IP - 7 DP - 2014 Jul TI - Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes. PG - 575-82 LID - 10.1139/cjpp-2014-0059 [doi] AB - Regular exercise is a great medicine with its benefits encompassing everything from prevention of cardiovascular risk to alleviation of different muscular myopathies. Interestingly, elevated levels of homocysteine (Hcy), also known as hyperhomocysteinemia (HHcy), antagonizes beta-2 adrenergic receptors (beta2AR), gamma amino butyric acid (GABA), and peroxisome proliferator-activated receptor-gamma (PPARgamma) receptors. HHcy also stimulates an elevation of the M1/M2 macrophage ratio, resulting in a more inflammatory profile. In this review we discuss several potential targets altered by HHcy that result in myopathy and excessive fat accumulation. Several of these HHcy mediated changes can be countered by exercise and culminate into mitigation of HHcy induced myopathy and metabolic syndrome. We suggest that exercise directly impacts levels of Hcy, matrix metalloproteinase 9 (MMP-9), macrophages, and G-protein coupled receptors (GPCRs, especially Gs). While HHcy promotes the M1 macrophage phenotype, it appears that exercise may diminish the M1/M2 ratio, resulting in a less inflammatory phenotype. HHcy through its influence on GPCRs, specifically beta(2)AR, PPARgamma and GABA receptors, promotes accumulation of white fat, whereas exercise enhances the browning of white fat and counters HHcy-mediated effects on GPCRs. Alleviation of HHcy-associated pathologies with exercise also includes reversal of excessive MMP-9 activation. Moreover, exercise, by reducing plasma Hcy levels, may prevent skeletal muscle myopathy, improve exercise capacity and rescue the obese phenotype. The purpose of this review is to summarize the pathological conditions surrounding HHcy and to clarify the importance of regular exercise as a method of disease prevention. FAU - Winchester, Lee AU - Winchester L AD - Department of Physiology & Biophysics, University of Louisville, Louisville, KY 40202, USA. FAU - Veeranki, Sudhakar AU - Veeranki S FAU - Givvimani, Srikanth AU - Givvimani S FAU - Tyagi, Suresh C AU - Tyagi SC LA - eng GR - HL108621/HL/NHLBI NIH HHS/United States GR - HL4718/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review DEP - 20140522 PL - Canada TA - Can J Physiol Pharmacol JT - Canadian journal of physiology and pharmacology JID - 0372712 RN - 0 (Receptors, G-Protein-Coupled) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) RN - Homocysteinemia SB - IM MH - Adipocytes, White/*metabolism MH - Animals MH - *Exercise MH - Humans MH - Hyperhomocysteinemia/complications/*metabolism/*pathology MH - Inflammation/metabolism MH - Macrophages/*metabolism MH - Matrix Metalloproteinase 9/*metabolism MH - Metabolic Syndrome/etiology/prevention & control MH - Muscle, Skeletal/*metabolism MH - Muscular Diseases/etiology/prevention & control MH - Receptors, G-Protein-Coupled/metabolism OTO - NOTNLM OT - GPCR OT - MMP-9 OT - PPAR OT - RCPG OT - cardiovasculaire OT - cardiovascular OT - exercice OT - exercise OT - homocysteine OT - homocysteine OT - macrophage OT - muscle squelettique OT - skeletal muscle EDAT- 2014/06/14 06:00 MHDA- 2015/05/12 06:00 CRDT- 2014/06/14 06:00 PHST- 2014/06/14 06:00 [entrez] PHST- 2014/06/14 06:00 [pubmed] PHST- 2015/05/12 06:00 [medline] AID - 10.1139/cjpp-2014-0059 [doi] PST - ppublish SO - Can J Physiol Pharmacol. 2014 Jul;92(7):575-82. doi: 10.1139/cjpp-2014-0059. Epub 2014 May 22.